Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Asahikawa-shi
Clinical trial register · Japan

Clinical Trials in Asahikawa-shi, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Asahikawa-shi

17 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
AstraZeneca
Phase 3
7,000
Aira, Akita, Asahikawa-shi, Chūōku, Fujisawa-shi, Fukuoka, Hachioji-shi, Hamamatsu
2026-08-21
Recruiting
AstraZeneca
Phase 3
600
Asahikawa-shi, Kamakura-shi, Kashiwa-shi, Kobe, Komoro, Kumamoto, Kyoto, Miyazaki
2026-07-08
Recruiting
AstraZeneca
Phase 3
1,200
Asahikawa-shi, Chūōku, Kamakura-shi, Koga-shi, Kumamoto, Mitaka-shi, Mito, Miyazaki
2026-07-06
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Nagoya, Chiba, Kitakyushu-shi, Fukushima, Asahikawa-shi, Sapporo, Kobe, Kanazawa
2026-03-10
Recruiting
Generate Biomedicines
Phase 3
786
Seto-shi, Matsuyama, Fukui-shi, Iizuka-Shi, Isesaki-Shi, Hiroshima, Asahikawa-shi, Himeji
2026-01-20
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Nagoya-sh, Toyoake Shi, Asahikawa-shi, Suita, Suita-shi, Ōtsu, Chūōku, Fukuoka
2025-09-22
Recruiting
AbbVie
Observational
700
Maebashi, Asahikawa-shi, Sapporo, Kagoshima, Isehara, Yokohama, Kyoto, Kurashiki
2025-09-09
Recruiting
Boehringer Ingelheim
Phase 2
300
Asahikawa-shi, Chofu-shi, Hachioji-shi, Kita-gun, Kurume-shi, Matsumoto-shi, Meguro-ku, Nagayoga
2025-06-05
Recruiting
AstraZeneca
Phase 3
15,100
Ami-machi, Asahi-shi, Asahikawa-shi, Bunkyō City, Chiyoda-ku, Chūōku, Fujisawa-shi, Fukui-shi
2025-06-04
Recruiting
Hoffmann-La Roche
Phase 3
600
Asahikawa-shi, Takamatsu, Sendai, Aichi, Aomori, Chiba, Chikushino-shi, Ehime
2025-03-17
Recruiting
AstraZeneca
Phase 3
11,300
Amagasaki-shi, Asahikawa-shi, Azumino-shi, Chūōku, Fukui-shi, Hakusan-shi, Himeji, Izumo-shi
2025-03-14
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Asahikawa-Shi, Chiba, Chuo-Shi, Fukuoka, Isehara, Izumo, Kurashiki-Shi, Kurume
2024-08-30
Recruiting
AstraZeneca
Phase 3
240
Asahikawa-Shi, Bunkyō City, Chiba, Fukuoka, Hiroshima, Iruma-Gun, Kawachinagano-shi, Kawasaki-shi
2024-06-20
Active, closed
AbbVie
Observational
1,200
Nagoya, Toyoake, Hirosaki, Chiba, Sakura, Fukuoka, Fukushima, Asahikawa-shi
2024-02-19
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Nagoya, Toyohira-ku, Sapporo City, Matsusaka-Shi, Sakai-shi Kita-ku, Shizuoka-Shi Aoi-Ku, Asahikawa-shi, Chikushino-shi, Chūō
2023-06-28
Active, closed
AbbVie
Observational
1,019
Nagoya, Hirosaki-shi, Chiba, Sakura-shi, Chikushino-shi, Fukuoka, Asahikawa-shi, Sapporo
2023-06-09
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 2
381
Asahikawa-shi, Chiba, Chūōku, Hiroshima, Kagoshima, Kawagoe-shi, Kita-gun, Sapporo
2022-09-16
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-japan/city/asahikawa-shi

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Asahikawa-shi.

How many clinical trials are recruiting in Asahikawa-shi?

12 of the 17 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Asahikawa-shi), 17 studies
PhaseStudiesRecruitingShare
Phase 3121070.6%
Observational3117.6%
Phase 22111.8%

Most active sponsors

Lead sponsors with the most studies (Asahikawa-shi)
Lead sponsorStudiesRecruiting
AstraZeneca66
AbbVie31
Boehringer Ingelheim21
Hoffmann-La Roche21
Bristol-Myers Squibb11
EMD Serono Research & Development Institute, Inc.11
Generate Biomedicines11
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.